Expression of cell adhesion molecules and tumour infiltrating leucocytes in conjunctival melanoma

Melanoma Research

Volumn 14, Issue 5, 2004, Pages 381-385

  Anastassiou, Gerasimos ^a   Esser, Markus ^a   Bader, Elisabeth ^a   Steuhl, Klaus Peter ^a   Bornfeld, Norbert ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Adhesion molecules; CD3; CD68; Conjunctival melanoma; ICAM 1; NCAM; VCAM 1

Indexed keywords

CD3 ANTIGEN; CD68 ANTIGEN; CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; MONOCLONAL ANTIBODY; NERVE CELL ADHESION MOLECULE; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONJUNCTIVA TUMOR; CONTROLLED STUDY; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE SYSTEM; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MELANOMA; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; RISK ASSESSMENT; STAINING; TUMOR ASSOCIATED LEUKOCYTE; TUMOR CELL; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL ADHESION; CELL LINE, TUMOR; CONJUNCTIVAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MELANOMA; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PROPORTIONAL HAZARDS MODELS; TIME FACTORS;

EID: 7244225178     PISSN: 09608931     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008390-200410000-00008     Document Type: Article

References (20)

1. Lommatzsch PK, Lommatzsch RE, Kirsch I, Fuhrmann P. Therapeutic outcome of patients suffering from malignant melanomas of the conjunctiva. Br J Ophthalmol 1990; 74(10):615-619.
2. Seregard S, Kock E. Conjunctival malignant melanoma in Sweden 1969-91. Acta Ophthalmol (Copenh) 1992; 70(3):289-296.
3. Norregaard JC, Gerner N, Jensen OA, Prause JU. Malignant melanoma of the conjunctiva: occurrence and survival following surgery and radiotherapy in a Danish population. Graefes Arch Clin Exp Ophthalmol 1996; 234(9):569-572.
4. Paridaens AD, Minassian DC, McCartney AC, Hungerford JL. Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases. Br J Ophthalmol 1994; 78(4):252-259.
5. Springer TA. Adhesion receptors of the immune system. Nature 1990; 346(6283):425-434.
6. Dustin ML, Springer TA. Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 1991; 9:27-66.
7. Fuchs U, Kivela T, Liesto K, Tarkkanen A. Prognosis of conjunctival melanomas in relation to histopathological features. Br J Cancer 1989; 59(2):261-267.
8. Anastassiou G, Heiligenhaus A, Bechrakis N, Bader E, Bornfeld N and Steuhl KP. Prognostic value of clinical and histopathological parameters in conjunctival melanomas: a retrospective study. Br J Ophthalmol 2002; 86(2):163-167.
9. Niederkorn JY. Immunoregulation of intraocular tumours. Eye 1997; 11:249-254.
10. Anastassiou G, Schilling H, Stang A, Djakovic S, Heiligenhaus A and Bornfeld N. Expression of the cell adhesion molecules ICAM-1, VCAM-1 and NCAM in uveal melanoma: a clinicopathological study. Oncology 2000; 58(1):83-88.
11. Mooy CM, Luyten GP, de Jong PT, Jensen OA, Luider TM, van der Ham F, et al. Neural cell adhesion molecule distribution in primary and metastatic uveal melanoma. Hum Pathol 1995; 26(11):1185-1190.
12. Lehmann JM, Riethmuller G, Johnson JP. MUC18, a marker of tumor progression in human melanoma, shows sequence similarity to the neural cell adhesion molecules of the immunoglobulin superfamily. Proc Natl Acad Sci USA 1989; 86(24):9891-9895.
13. Carrel S, Schreyer M, Gross N, Zografos L. Surface antigenic profile of uveal melanoma lesions analysed with a panel of monoclonal antibodies directed against cutaneous melanoma. Anticancer Res 1990; 10(1):81-89.
14. Denton KJ, Stretch JR, Gatter KC, Harris AL. A study of adhesion molecules as markers of progression in malignant melanoma. J Pathol 1992; 167(2):187-191.
15. van der Pol JP, Jager MJ, de Wolff-Rouendaal D, Ringens PJ, Vennegoor C, Ruiter DJ. Heterogeneous expression of melanoma-associated antigens in uveal melanomas. Curr Eye Res 1987; 6(6):757-765.
16. Johnson JP, Stade BG, Holzmann B, Schwable W, Riethmuller G. De novo expression of intercellular-adhesion molecule 1 in melanoma correlates with increased risk of metastasis. Proc Natl Acad Sci USA 1989; 86(2):641-644.
17. Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci 2001; 42(7):1414-1421.
18. Whelchel JC, Farah SE, McLean IW, Burnier MN. Immunohistochemistry of infiltrating lymphocytes in uveal malignant melanoma. Invest Ophthalmol Vis Sci 1993; 34(8):2603-2606.
19. Anastassiou G, Coupland SE, Stang A, Boeloeni R, Schilling H, Bornfeld N. Expression of Fas and Fas ligand in uveal melanoma: biological implication and prognostic value. J Pathol 2001; 194(4):465-471.
20. de la Cruz PO, Jr, Specht CS, McLean IW. Lymphocytic infiltration in uveal malignant melanoma. Cancer 1990; 65(1):112-115.